142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

Federal Recommendations and National Data

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 9:30 AM - 9:50 AM

Grant Baldwin, PhD, MPH , Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA
Deaths from drug overdose steadily increased over the past two decades and are the leading cause of injury death in the U.S.  Among 25 to 64 year-olds, drug overdose causes more deaths than motor vehicle traffic crashes. Of the 22,134 deaths relating to prescription drug overdose in 2010, 75% involved opioid analgesics. Description: Federal partners play an important role in supporting state action to address prescription drug misuse and abuse.   The Centers for Disease Control and Prevention will highlight current data and evidence based recommendations for states and local partners to use to address the opioid epidemic across the nation.

Learning Areas:

Public health administration or related administration
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy

Learning Objectives:
Describe data on prescription drug abuse and misuse. Identify and discuss federal efforts to address prescription drug abuse and misuse.

Keyword(s): Public Health Research, Public Health Policy

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been the Division Director, of the Division of Unintentional Injury Prevention, within the National Center of Injury Prevention and Control, since 2008. The division is dedicated to reducing the number and severity of unintentional injuries through science-based programs and applied research. Additionally, I am an adjunct Assistant Professor in the Department of Behavioral Sciences and Health Education for the Rollins School of Public Health at Emory University.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.